Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review
- 31 January 2017
- journal article
- case report
- Published by Springer Nature in Mycopathologia
- Vol. 182 (7-8) , 709-713
Abstract
Invasive fungal infection is a serious complication following allogeneic hematopoietic stem cell transplantation. Pulmonary infection due to Hormographiella aspergillata is an uncommon condition associated with a high mortality rate. The susceptibility of H. aspergillata to available antifungal agents is not well established. We report for the first time a case of H. aspergillata lung infection that responded poorly to conventional treatment with liposomal amphotericin B (LAmB; 3 mg kg−1 of body weight per day) with renal damage at higher posology (5 mg kg−1 of body weight per day), but improved rapidly after addition of nebulized LAmB to intravenous LAmB (3 mg kg−1 of body weight per day). Successful treatment of our patient using nebulized LAmB would be worth evaluating in cases refractory to standard treatment or when the reference treatment may not be extended due to interaction or side effects.Keywords
This publication has 26 references indexed in Scilit:
- Breakthrough invasive mould infections in patients treated with caspofunginJournal of Infection, 2012
- Hormographiella aspergillata: an emerging mould in acute leukaemia patients?Clinical Microbiology and Infection, 2011
- Breakthrough Hormographiella aspergillata Infections Arising in Neutropenic Patients Treated Empirically with CaspofunginJournal of Clinical Microbiology, 2011
- Rhizomucor variabilis var. regularior and Hormographiella aspergillata Infections in a Leukemic Bone Marrow Transplant Recipient with Refractory NeutropeniaJournal of Clinical Microbiology, 2009
- Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance RegistryClinical Infectious Diseases, 2009
- Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and SafetyThe Journal of Heart and Lung Transplantation, 2009
- Comparison of Epidemiological, Clinical, and Biological Features of Invasive Aspergillosis in Neutropenic and Nonneutropenic Patients: A 6‐Year SurveyClinical Infectious Diseases, 2006
- Fatal pulmonary infection in a leukaemic patient caused by Hormographiella aspergillataJournal of Medical Microbiology, 2005
- Efficacy and feasibility of aerosolized amphotericin B lipid complex therapy in caspofungin breakthrough pulmonary zygomycosisBone Marrow Transplantation, 2004
- Tracheobronchial aspergillosis in a patient with AIDS treated with aerosolized amphotericin B combined with itraconazoleMycoses, 1996